See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2014

PERFECT-Phase III Clinical TrialKey Study Elements

Presenter: Gustav Steinhoff

January 22, 2014

Presentation Cell Therapy 2014

Repetitive BMC Therapy in Chronic Heart Failure: Rationale and Design of the REPEAT Trial

Presenter: Birgit Assmus

January 22, 2014

Presentation Cell Therapy 2014

Enabling Full Automation of Cell Processing

Presenter: Normand Pilon

January 22, 2014

Presentation Cell Therapy 2014

Cell Therapy for Non-ST Elevation MI: A Phase 1 Study

Presenter: Marc S. Penn

January 22, 2014

Presentation Cell Therapy 2014

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Presenter: Micha? Tendera

January 22, 2014

Presentation Cell Therapy 2014

CXCR4 AnTagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)

Presenter: Jonathan Hill

January 22, 2014

Presentation Cell Therapy 2014

LV Augmentation for the Treatment of Heart Failure

Presenter: Randy Lee

January 22, 2014

Presentation Cell Therapy 2014

Cardiosphere Derived Cells for Myocardial Repair: CADUCEUS and ALLSTAR programs

Presenter: Raj R. Makkar

January 22, 2014

Presentation Cell Therapy 2014

12 months CMR and long-term clinical results of the Swiss AMI Study

Presenter: Daniel S?rder

January 22, 2014

Presentation Cell Therapy 2014

New Insights into Paracrine Activity of Stem Cells in Heart Repair - Microvesicles and Proteomics

Presenter: Ewa K. Zuba-Surma

January 21, 2014

Advertisement

Slides

PERFECT-Phase III Clinical TrialKey Study Elements

Repetitive BMC Therapy in Chronic Heart Failure: Rationale and Design of the REPEAT Trial

Enabling Full Automation of Cell Processing

Cell Therapy for Non-ST Elevation MI: A Phase 1 Study

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

CXCR4 AnTagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)

LV Augmentation for the Treatment of Heart Failure

Cardiosphere Derived Cells for Myocardial Repair: CADUCEUS and ALLSTAR programs

12 months CMR and long-term clinical results of the Swiss AMI Study

New Insights into Paracrine Activity of Stem Cells in Heart Repair - Microvesicles and Proteomics

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content